试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-20
PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
编号:NCT04142658登记状态:提前终止企业 / 申办者:Artivion Inc.
药物 / 成分:Apixaban 5 MG、Apixaban 2.5 MG、Warfarin、On-X Aortic Mechanical Valve
登记的停止原因(原文):Safety
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-20
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
编号:NCT05942820登记状态:提前终止企业 / 申办者:Bugworks Research Inc.
药物 / 成分:BWC0977、Placebo
登记的停止原因(原文):CMC challenges
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-19
Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
编号:NCT04083898登记状态:提前终止企业 / 申办者:Washington University School of Medicine
药物 / 成分:Isatuximab、Bendamustine、Prednisone
登记的停止原因(原文):Decision made to not move forward with Phase II portion of trial
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-19
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)
编号:NCT04483479登记状态:提前终止企业 / 申办者:Enterin Inc.
药物 / 成分:Active Investigational Treatment ENT-01
登记的停止原因(原文):Poor recruitment/retention due to the pandemic. Data was not analyzed due to early termination.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-19
Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen
编号:NCT04534881登记状态:提前终止企业 / 申办者:St. Louis University
药物 / 成分:Progesterone 200 MG、Placebo
登记的停止原因(原文):lack of recruitment
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-19
Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients
编号:NCT04793399登记状态:提前终止企业 / 申办者:Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica
药物 / 成分:Bosutinib 400 MG Monotherapy、Bosutinib 400 MG + Atezolizumab 840 MG in 14 ML Injection
登记的停止原因(原文):The study has been prematurely terminated due to the onset of 2 dose limiting toxicities in 2 patients.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-18
Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment
编号:NCT01199783登记状态:提前终止企业 / 申办者:Ruhr University of Bochum
药物 / 成分:Daptomycin、Vancomycin
登记的停止原因(原文):Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-18
Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)
编号:NCT01311674登记状态:提前终止企业 / 申办者:Emergent BioSolutions
药物 / 成分:hepatitis B vaccine、hepatitis B vaccine
登记的停止原因(原文):Prematurely terminated due to failure to meet study objectives.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-18
Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects
编号:NCT02696291登记状态:提前终止企业 / 申办者:Emergent BioSolutions
药物 / 成分:UV-4B 30 mg oral solution、UV-4B 75 mg oral solution、UV-4B 150 mg oral solution、UV-4B X mg (dose to be determined) oral solution
登记的停止原因(原文):Product development halted for business reasons.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-03-18
Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults
编号:NCT02771730登记状态:提前终止企业 / 申办者:Emergent BioSolutions
药物 / 成分:Ad4-mgag、Ad4-EnvC150、Placebo Comparator、AIDSVAX B/E
登记的停止原因(原文):Study endpoints not met.
查看官方原始记录 ↗